School of Medicine

Two WashU Medicine researchers have received three-year, $750,000 awards from the Edward P. Evans Foundation to advance the study of certain types of blood cancer.

WashU Medicine researchers have found in mice that two types of immune cells are involved in triggering strong cancer-killing T-cell responses with mRNA vaccines, offering new insights into designing cancer vaccines.

A study by WashU Medicine researchers offers new insight into how environmental factors protect against opioid addiction and support recovery.

A clinical trial co-led by WashU Medicine researchers has shown that a painful complication of blood clots can be treated by inserting a stent into the affected vein.

New research from Washington University in St. Louis shows that a mother helps to set the biological clock for her babies while they are still in the womb.

Milan G. Chheda, MD, at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation.

WashU Medicine researchers have developed a software, De-ID, that flags sensitive information in data collected through focus groups, surveys and interviews. It allows for easy removal of such details to enable safe sharing.

New research from WashU Medicine adds to growing evidence that helping brain cells break down and eliminate their own cellular waste is a promising treatment strategy for a variety of neurodegenerative diseases.

The CONNECT program at WashU Medicine streamlines clinical services to provide timely, research-based mental health care that helps teens who have experienced trauma and suicide ideation.

Developed by WashU Medicine researchers and licensed to WashU startup Wugen, the immunotherapy is designed to treat rare and aggressive types of blood cancer.